Home › Lymphoma › Indiana › Indianapolis
Lymphoma clinical trials in Indianapolis, IN
5 studies for Lymphoma are looking for participants at sites in and around Indianapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
RecruitingPhase 2
- Hematology Oncology of Indiana, Indianapolis
Collection of Tissue Samples for Cancer Research
RecruitingObservational study
- Indiana University - Purdue, Indianapolis
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
RecruitingPhase 1/2
- Riley Hospital for Children, Indianapolis
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RecruitingPhase 1/2
- Indiana Blood and Marrow Transplantation, Indianapolis
CD4CAR for CD4+ Leukemia and Lymphoma
RecruitingPhase 1
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
- Riley Hospital for Children, Indianapolis
About Lymphoma
Lymphoma is a cancer affecting the immune system. Hodgkins Lymphoma and Non Hodgkins Lymphoma are types of lymphoma. Learn about symptoms and treatments.
More about Lymphoma on MedlinePlus
Lymphoma trials in other cities
- Houston, TX34 studies
- New York City, NY33 studies
- Boston, MA33 studies
- Washington, DC23 studies
- Baldwin Park, CA21 studies
- Chicago, IL20 studies
- Durham, NC17 studies
- Philadelphia, PA15 studies
- St. Louis, MO15 studies
- Cleveland, OH13 studies
- Edison, NJ12 studies
- Seattle, WA12 studies
Other studies in Indianapolis
- Non-Small Cell Lung Cancer32 studies
- Cancer (all types)25 studies
- Heart Failure23 studies
- Obesity20 studies
- Breast Cancer20 studies
- Metastatic Cancer19 studies
- Colorectal Cancer18 studies
- Ovarian Cancer17 studies
- Cardiovascular Disease16 studies
- Lung Cancer16 studies
- Endometrial Cancer15 studies
- Alzheimer's Disease14 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.